1. Home
  2. CELU vs ASRV Comparison

CELU vs ASRV Comparison

Compare CELU & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • ASRV
  • Stock Information
  • Founded
  • CELU 2016
  • ASRV 1983
  • Country
  • CELU United States
  • ASRV United States
  • Employees
  • CELU N/A
  • ASRV N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • ASRV Major Banks
  • Sector
  • CELU Health Care
  • ASRV Finance
  • Exchange
  • CELU Nasdaq
  • ASRV Nasdaq
  • Market Cap
  • CELU 42.2M
  • ASRV 40.3M
  • IPO Year
  • CELU N/A
  • ASRV N/A
  • Fundamental
  • Price
  • CELU $1.82
  • ASRV $2.44
  • Analyst Decision
  • CELU
  • ASRV
  • Analyst Count
  • CELU 0
  • ASRV 0
  • Target Price
  • CELU N/A
  • ASRV N/A
  • AVG Volume (30 Days)
  • CELU 162.2K
  • ASRV 19.4K
  • Earning Date
  • CELU 12-06-2024
  • ASRV 04-15-2025
  • Dividend Yield
  • CELU N/A
  • ASRV 4.86%
  • EPS Growth
  • CELU N/A
  • ASRV N/A
  • EPS
  • CELU N/A
  • ASRV 0.21
  • Revenue
  • CELU $48,200,000.00
  • ASRV $53,139,000.00
  • Revenue This Year
  • CELU N/A
  • ASRV N/A
  • Revenue Next Year
  • CELU $233.89
  • ASRV N/A
  • P/E Ratio
  • CELU N/A
  • ASRV $11.62
  • Revenue Growth
  • CELU 225.94
  • ASRV 18.14
  • 52 Week Low
  • CELU $1.00
  • ASRV $2.20
  • 52 Week High
  • CELU $5.69
  • ASRV $3.06
  • Technical
  • Relative Strength Index (RSI)
  • CELU 48.24
  • ASRV 45.54
  • Support Level
  • CELU $1.64
  • ASRV $2.33
  • Resistance Level
  • CELU $2.40
  • ASRV $2.52
  • Average True Range (ATR)
  • CELU 0.20
  • ASRV 0.11
  • MACD
  • CELU 0.03
  • ASRV 0.01
  • Stochastic Oscillator
  • CELU 26.26
  • ASRV 45.45

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

Share on Social Networks: